NORWOOD, Mass.--(BUSINESS WIRE)--Aspect Medical Systems, Inc. (NASDAQ: ASPM) is presenting two abstracts at the Alzheimer’s Association International Conference on Prevention of Dementia being held in Washington, D.C. June 9-12, 2007. The abstracts report on interim results of two studies that are investigating use of the company’s brain assessment technology to evaluate cognitive function in elderly patients. These study results are consistent with previous findings that Aspect’s EEG-based biomarker correlates with standard measures of cognitive performance and suggest that the EEG information may be helpful in determining which patients in the normal to mild cognitive impairment range are likely to experience cognitive decline.
